240 families are concerned about the effects of defective meningitis vaccines on the health of their children. They seek redress in court.
They are 240 families to meet this Tuesday before the Tribunal de Grande Instance of Clermont-Ferrand. First legal battle against the CSP laboratory, the French distributor of the meningitis vaccine (meningitec).
Last September, the National Medicines and Health Products Agency (ANSM) requested the withdrawal of 21 defective batches whose syringes contained traces of heavy metals. Despite this injunction, they were still distributed and marketed in several French pharmacies.
First hearing
The hearing of the day is only the first legal aspect of this health scandal. The plaintiffs’ lawyer, Maître Emmanuel Ludot, should request that independent expert opinions be carried out on vaccinated children, in order to detect possible traces of heavy metals in their bodies. A second hearing will then take place on October 20.
Initial hair tests have already highlighted the presence of lead, tin, silicon and aluminum in patients, who present with severe symptoms, ranging from vomiting to feverish flares, including skin rashes.
Procedures abroad
If the responsibility of the laboratory could be engaged, Maître Ludot believes that the health authorities and pharmacies have also played a significant role, by not taking the threat posed by these batches seriously enough.
The French are not the only ones concerned. In Italy, Brazil, Australia and even New Zealand, similar legal proceedings have reportedly been launched following the spread in these countries of the defective vaccine.
In France, the meningococcal C vaccine is not compulsory, but strongly recommended for all infants, with a catch-up possible up to the age of 24 years.
.
